DK1144386T3 - Polymorf form af telmisartan, fremgangsmåde til fremstilling deraf og anvendelse deraf til fremstilling af et lægemiddel - Google Patents
Polymorf form af telmisartan, fremgangsmåde til fremstilling deraf og anvendelse deraf til fremstilling af et lægemiddelInfo
- Publication number
- DK1144386T3 DK1144386T3 DK00901510T DK00901510T DK1144386T3 DK 1144386 T3 DK1144386 T3 DK 1144386T3 DK 00901510 T DK00901510 T DK 00901510T DK 00901510 T DK00901510 T DK 00901510T DK 1144386 T3 DK1144386 T3 DK 1144386T3
- Authority
- DK
- Denmark
- Prior art keywords
- telmisartan
- drug
- manufacture
- preparation
- polymorphic form
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19901921A DE19901921C2 (de) | 1999-01-19 | 1999-01-19 | Polymorphe von Telmisartan, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung eines Arzneimittels |
PCT/EP2000/000065 WO2000043370A1 (de) | 1999-01-19 | 2000-01-07 | Polymorphe von telmisartan, verfahren zu deren herstellung und deren verwendung zur herstellung eines arzneimittels |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1144386T3 true DK1144386T3 (da) | 2004-01-12 |
Family
ID=7894715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00901510T DK1144386T3 (da) | 1999-01-19 | 2000-01-07 | Polymorf form af telmisartan, fremgangsmåde til fremstilling deraf og anvendelse deraf til fremstilling af et lægemiddel |
Country Status (36)
Country | Link |
---|---|
EP (1) | EP1144386B1 (da) |
JP (1) | JP4700813B2 (da) |
KR (1) | KR100658959B1 (da) |
CN (1) | CN1144790C (da) |
AR (1) | AR035475A1 (da) |
AT (1) | ATE252564T1 (da) |
AU (1) | AU765081B2 (da) |
BG (1) | BG65027B1 (da) |
BR (1) | BR0007584A (da) |
CA (1) | CA2352436C (da) |
CO (1) | CO5150238A1 (da) |
CZ (1) | CZ297412B6 (da) |
DE (2) | DE19901921C2 (da) |
DK (1) | DK1144386T3 (da) |
EA (1) | EA003065B1 (da) |
EE (1) | EE04344B1 (da) |
ES (1) | ES2208265T3 (da) |
HK (1) | HK1041485B (da) |
HR (1) | HRP20010514B1 (da) |
HU (1) | HU227401B1 (da) |
IL (2) | IL143634A0 (da) |
MY (1) | MY122755A (da) |
NO (1) | NO319823B1 (da) |
NZ (1) | NZ513528A (da) |
PE (1) | PE20001362A1 (da) |
PL (1) | PL211829B1 (da) |
PT (1) | PT1144386E (da) |
RS (1) | RS50044B (da) |
SA (1) | SA99200838B1 (da) |
SK (1) | SK285429B6 (da) |
TR (1) | TR200102074T2 (da) |
TW (1) | TWI280241B (da) |
UA (1) | UA56358C2 (da) |
UY (1) | UY25980A1 (da) |
WO (1) | WO2000043370A1 (da) |
ZA (1) | ZA200104771B (da) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10153737A1 (de) * | 2001-10-31 | 2003-05-28 | Boehringer Ingelheim Pharma | Kristallines Natriumsalz des Telmisartans, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels |
US6737432B2 (en) | 2001-10-31 | 2004-05-18 | Boehringer Ingelheim Pharma Kg | Crystalline form of telmisartan sodium |
PT2260833E (pt) * | 2002-01-16 | 2012-12-26 | Boehringer Ingelheim Pharma | Comprimido farmacêutico de duas camadas compreendendo telmisartan e um diurético |
DE10314702A1 (de) | 2003-03-31 | 2004-10-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung von Telmisartan |
GB2414019A (en) * | 2004-05-11 | 2005-11-16 | Cipla Ltd | One-step preparation of telmisartan by condensation and hydrolysis |
KR20070061583A (ko) | 2004-10-15 | 2007-06-13 | 테바 파마슈티컬 인더스트리즈 리미티드 | 텔미사르탄의 제조 방법 |
US7943781B2 (en) | 2004-10-18 | 2011-05-17 | Dr. Reddy's Laboratories Limited | Process for preparing telmisartan |
US8637078B2 (en) | 2005-11-24 | 2014-01-28 | Boehringer Ingelheim International Gmbh | Bilayer tablet comprising telmisartan and diuretic |
EP1908469A1 (en) | 2006-10-06 | 2008-04-09 | Boehringer Ingelheim Vetmedica Gmbh | Angiotensin II receptor antagonist for the treatment of systemic diseases in cats |
DE102008059206A1 (de) | 2008-11-27 | 2010-06-10 | Bayer Schering Pharma Aktiengesellschaft | Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum |
CA2761576C (en) | 2009-05-20 | 2017-08-22 | Boehringer Ingelheim Vetmedica Gmbh | Oral suspension comprising telmisartan |
ES2415357T3 (es) | 2009-06-19 | 2013-07-25 | Krka Tovarna Zdravil, D.D., Novo Mesto | Procedimiento para la preparación de telmisartán |
EP2277866A1 (en) | 2009-06-22 | 2011-01-26 | Inke, S.A. | Process for preparing telmisartan |
WO2011002425A2 (en) | 2009-07-02 | 2011-01-06 | Bilgig Mahmut | Pharmaceutical composition increasing solubility and stability |
EP2448576A2 (en) | 2009-07-02 | 2012-05-09 | Mahmut Bilgic | Solubility enhancing pharmaceutical composition |
EP2632438A1 (en) | 2010-10-27 | 2013-09-04 | KRKA, tovarna zdravil, d.d., Novo mesto | Multilayer pharmaceutical composition comprising telmisartan and amlodipine |
ITMI20102416A1 (it) * | 2010-12-27 | 2012-06-28 | Chemelectiva S R L | Intermedio per la preparazione di un principio attivo e processo per la sua preparazione |
EP2612658A1 (en) | 2012-01-05 | 2013-07-10 | Laboratorios Lesvi, S.L. | Pharmaceutical compositions of 4'-[(1,4'dimethyl-2'-propyl[2,6'-bi-1h-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid and is 6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide |
JP6147546B2 (ja) * | 2013-04-10 | 2017-06-14 | 株式会社トクヤマ | 酢酸が低減されたテルミサルタンa型結晶の製造方法 |
EP2979691A1 (en) | 2014-07-30 | 2016-02-03 | Boehringer Ingelheim International GmbH | Oral disintegrating tablet |
JP6275596B2 (ja) * | 2014-09-03 | 2018-02-07 | 株式会社トクヤマ | テルミサルタンのアンモニウム塩の製造方法 |
JP5871294B1 (ja) | 2015-02-27 | 2016-03-01 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 即時放出経口錠剤 |
KR20170001921A (ko) | 2015-06-26 | 2017-01-05 | 대원제약주식회사 | 안정성이 개선된 텔미사르탄을 함유하는 약제학적 조성물 및 이의 제조방법 |
KR20170012703A (ko) | 2015-07-22 | 2017-02-03 | 대원제약주식회사 | 텔미사르탄을 함유하는 약제학적 조성물 및 이의 제조방법 |
JP6411662B2 (ja) | 2016-05-30 | 2018-10-24 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 固定容量配合剤 |
KR102044223B1 (ko) * | 2016-09-12 | 2019-11-13 | 성균관대학교산학협력단 | 텔미사르탄을 포함하는 고체 분산체 및 이의 제조방법 |
CN106749037B (zh) * | 2016-12-21 | 2019-06-21 | 山东大学 | 一种无定型的替米沙坦-戊二酸共晶及其制备方法和应用 |
CN106749036B (zh) * | 2016-12-21 | 2019-06-21 | 山东大学 | 一种无定型的替米沙坦-庚二酸共晶及其制备方法和应用 |
JP7050893B2 (ja) | 2017-07-07 | 2022-04-08 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー | ネコの全身性疾患の予防又は治療用アンジオテンシンii受容体拮抗薬 |
CN109851562A (zh) * | 2019-01-30 | 2019-06-07 | 浙江省食品药品检验研究院 | 一种替米沙坦晶体及其制备方法 |
WO2023001880A1 (en) | 2021-07-22 | 2023-01-26 | Krka, D. D., Novo Mesto | Bilayer tablet comprising telmisartan and indapamide |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI9210098B (sl) * | 1991-02-06 | 2000-06-30 | Dr. Karl Thomae | Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo |
US5139114A (en) * | 1991-03-18 | 1992-08-18 | Abex Corporation | Visible brake block wear indicator |
-
1999
- 1999-01-19 DE DE19901921A patent/DE19901921C2/de not_active Expired - Fee Related
- 1999-12-17 PE PE1999001284A patent/PE20001362A1/es not_active Application Discontinuation
- 1999-12-26 SA SA99200838A patent/SA99200838B1/ar unknown
-
2000
- 2000-01-07 RS YUP-511/01A patent/RS50044B/sr unknown
- 2000-01-07 CN CNB00802880XA patent/CN1144790C/zh not_active Expired - Fee Related
- 2000-01-07 AT AT00901510T patent/ATE252564T1/de active
- 2000-01-07 IL IL14363400A patent/IL143634A0/xx active IP Right Grant
- 2000-01-07 DK DK00901510T patent/DK1144386T3/da active
- 2000-01-07 BR BR0007584-1A patent/BR0007584A/pt active Pending
- 2000-01-07 EE EEP200100375A patent/EE04344B1/xx not_active IP Right Cessation
- 2000-01-07 ES ES00901510T patent/ES2208265T3/es not_active Expired - Lifetime
- 2000-01-07 NZ NZ513528A patent/NZ513528A/en not_active IP Right Cessation
- 2000-01-07 CA CA2352436A patent/CA2352436C/en not_active Expired - Fee Related
- 2000-01-07 PT PT00901510T patent/PT1144386E/pt unknown
- 2000-01-07 TR TR2001/02074T patent/TR200102074T2/xx unknown
- 2000-01-07 EP EP00901510A patent/EP1144386B1/de not_active Expired - Lifetime
- 2000-01-07 KR KR1020017008958A patent/KR100658959B1/ko not_active IP Right Cessation
- 2000-01-07 SK SK1020-2001A patent/SK285429B6/sk not_active IP Right Cessation
- 2000-01-07 CZ CZ20012634A patent/CZ297412B6/cs not_active IP Right Cessation
- 2000-01-07 DE DE50004150T patent/DE50004150D1/de not_active Expired - Lifetime
- 2000-01-07 PL PL349425A patent/PL211829B1/pl unknown
- 2000-01-07 JP JP2000594786A patent/JP4700813B2/ja not_active Expired - Lifetime
- 2000-01-07 WO PCT/EP2000/000065 patent/WO2000043370A1/de active IP Right Grant
- 2000-01-07 HU HU0105148A patent/HU227401B1/hu not_active IP Right Cessation
- 2000-01-07 EA EA200100730A patent/EA003065B1/ru not_active IP Right Cessation
- 2000-01-07 AU AU22881/00A patent/AU765081B2/en not_active Ceased
- 2000-01-17 MY MYPI20000130A patent/MY122755A/en unknown
- 2000-01-17 TW TW089100637A patent/TWI280241B/zh not_active IP Right Cessation
- 2000-01-18 CO CO00002435A patent/CO5150238A1/es unknown
- 2000-01-18 UY UY25980A patent/UY25980A1/es not_active Application Discontinuation
- 2000-01-19 AR ARP000100241A patent/AR035475A1/es active Pending
- 2000-07-01 UA UA2001085811A patent/UA56358C2/uk unknown
-
2001
- 2001-06-07 IL IL143634A patent/IL143634A/en not_active IP Right Cessation
- 2001-06-12 ZA ZA200104771A patent/ZA200104771B/en unknown
- 2001-06-27 BG BG105654A patent/BG65027B1/bg active Active
- 2001-07-10 HR HR20010514A patent/HRP20010514B1/xx not_active IP Right Cessation
- 2001-07-18 NO NO20013560A patent/NO319823B1/no not_active IP Right Cessation
-
2002
- 2002-04-24 HK HK02103090.1A patent/HK1041485B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1144386T3 (da) | Polymorf form af telmisartan, fremgangsmåde til fremstilling deraf og anvendelse deraf til fremstilling af et lægemiddel | |
DK1180518T3 (da) | 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
NO20035696D0 (no) | Krystallinsk anti-cholinergikum, fremgangsmåte for fremstilling derav og anvendelse derav til fremstilling av et legemiddel | |
NO20031694L (no) | Krystallinsk monohydrat, fremgangsmåte for fremstilling derav og anvendelsederav til fremstilling av et medikament | |
DK1218341T3 (da) | Sulfonylcarboxamid-derivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel | |
DK1345910T3 (da) | Quinazolinderivater, lægemidler indeholdende forbindelserne, deres anvendelse og fremgangsmåde til fremstilling deraf | |
EE200100431A (et) | 16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine | |
IS5982A (is) | Aðferð til framleiðslu á 5-sýanóþalíði | |
NO20015149D0 (no) | Nytt farmasöytisk preparat | |
DK1275397T3 (da) | Lægemiddel til lokal anvendelse | |
DK1147075T3 (da) | Fremgangsmåde til fremstilling af L-phenylephrinhydrochlorid | |
EE200100422A (et) | Epotilooni derivaadid, nende valmistamismeetod jafarmatseutiline kasutamine | |
DK1202996T3 (da) | Titanforbindelser, fremstilling og anvendelse heraf | |
NO20015148D0 (no) | Nytt farmasöytisk preparat | |
IS7153A (is) | Aðferð til framleiðslu á 14-hýdroxýnormorfínon afleiðu | |
DK1627631T3 (da) | Morfinsulfatmikrogranuler, fremgangsmåde til fremstilling deraf og præparat omfattende samme | |
NO20010219L (no) | Polycykliske tiazolidin-2-ylidenaminer, fremgangsmÕte for deres fremstilling og deres anvendelse som legemiddel | |
NO20001909D0 (no) | Fremgangsmõte og anlegg for fremstilling av 1,2-dikloretan | |
NO20015104L (no) | Nytt farmasöytisk preparat | |
DK1053224T3 (da) | Biphenylfulfonylcyanamider, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel | |
DE50201312D1 (de) | Metall-keramik-verbundwerkstoff und verfahren zu dessen herstellung | |
NO20015105L (no) | Nytt farmasöytisk preparat | |
NO20042022L (no) | Fast legemiddelformulering som inneholder pipiperazinurea-derivat og fremgangsmate for fremstilling av formuleringen | |
NO20021036L (no) | Farmasöytisk preparat | |
NO20020308D0 (no) | Fremgangsmåte for fremstilling av epothiolon B og derivater, såvel som mellomprodukter for fremgangsmåten |